Parkinson's Disease Trial, Recruiting NCT07567482 Sponsor: Centre intégré de santé et de services sociaux de l'Outaouais Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07567482
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have Parkinson's disease:

  • You are able to walk for at least 30 minutes, with or without some minor assistance
  • You have been diagnosed with Parkinson's disease that developed on its own (not caused by another condition)
  • Your Parkinson's disease has been rated between stage 1 and 4 on a standard scale used by doctors to measure how advanced the condition is (confirm with trial site)

If you are a healthy older adult without Parkinson's disease:

  • You are able to walk for at least 30 minutes, with or without some minor assistance
  • You are 65 years old or older

Who may not be able to join:

  • You are shorter than 152 cm (about 5 feet)
  • You have serious blood vessel or circulation problems in your legs that affect how you move or could put you at risk
  • You have an implanted or external medical device that keeps you alive, such as a pacemaker
  • You have been told you have severe bone thinning (osteoporosis) or that you are at high risk of breaking a bone
  • You have a medical reason why physical activity or exercise would not be safe for you (confirm with trial site)
  • You have significant difficulties with memory or thinking, based on a standard test score below a certain level (confirm with trial site)
  • You have another condition affecting the nervous system, an injury to your legs, or any other health problem — aside from Parkinson's disease — that affects your ability to move around normally

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 819-966-6200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre intégré de santé et de services sociaux de l'Outaouais
Registry
ClinicalTrials.gov
Start date
30 April 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Changes in Timed Up and Go (TUG) duration; Changes in 10 meters walk test (10MWT) walking speed; Changes in 5 repetitions sit-to-stand test (5STS) duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov